{"name":"Vertanical GmbH","slug":"vertanical-gmbh","ticker":"","exchange":"","domain":"vertanicalgmbh.com","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"Pharma / Biotech","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Oncology","slug":"oncology","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"oncology","drugs":[{"name":"Opioid therapy","genericName":"Opioid therapy","slug":"opioid-therapy","indication":"Chronic pain","status":"phase_3"}]},{"name":"Metabolic","slug":"metabolic","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"immunology","drugs":[{"name":"VER-01","genericName":"VER-01","slug":"ver-01","indication":"Type 2 diabetes","status":"phase_3"}]}],"pipeline":[{"name":"Opioid therapy","genericName":"Opioid therapy","slug":"opioid-therapy","phase":"phase_3","mechanism":"Opioid therapy involves binding to opioid receptors in the brain, spinal cord, and other areas to reduce pain perception.","indications":["Chronic pain","Cancer pain"],"catalyst":""},{"name":"VER-01","genericName":"VER-01","slug":"ver-01","phase":"phase_3","mechanism":"VER-01 is a small molecule that targets the SGLT2 receptor.","indications":["Type 2 diabetes"],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMiX0FVX3lxTE5PbHNtd2ZFWUM0MElSamxxRjA3UFlFa3F6UUhFS3g4WDRJdHdaUGtqeUtUSzlwS1lUaDRqczNtRXpQcDRTdnhmX2Qzb2VuemVFRXJhSFZ0M0dEWkhLTUE4?oc=5","date":"2025-09-29","type":"trial","source":"nature.com","summary":"Full-spectrum extract from Cannabis sativa DKJ127 for chronic low back pain: a phase 3 randomized placebo-controlled trial - nature.com","headline":"Full-spectrum extract from Cannabis sativa DKJ127 for chronic low back pain: a phase 3 randomized placebo-controlled tri","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMixgFBVV95cUxPcnhSbDlyR0RFX1JkT3J6RUY2bmZZSlcwTUlMbEdCMWRUandDMlQ0eTRqcG85a0syZGZSbFdlbW9QQVNNb2ZxNk9vQTJ6akpBODJhMXlldUZDQVNxeVBqQlBIS1pzUE1GN0hyaERFNWFPZUFuaUxBS2lqcUlqRklnUE9fQVNmc1F1YjZGYS0yQ2lEaEJWUE5idG8wYlhjTGZrYkF3cUZHck9fUmw5cE5xX09RaHFJZUd3SWQ3c2pGM3pqLXRROFE?oc=5","date":"2025-09-17","type":"pipeline","source":"Forbes","summary":"Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution - Forbes","headline":"Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi2gFBVV95cUxQdkJSZ2VaVkFBQWk5Ty1hSjdjV1k2RVNLc2dKaUpRZlp1QkhodERSTDZzSDh4dmk3SXktSUtOczE2MUJfcmdTZG9CTHlJcGg4SXUwcEpYYmJ1dUcyMVRYU003VWtGSHJaRnhpdXVjT0VPMGxIemt3Rm1YSTZmdGUxQlNoMk1id2dfUkdWYWpNSGhXTVpfanVrRW5SdnhxU0JkMHg5YWo2UXc4Wm5SY1NyV0VwZkdqNm9JYjFTOWtOUUM2X1pDWmJHY1hoaG5wUGdVZFU4S01PWTNmdw?oc=5","date":"2025-09-12","type":"pipeline","source":"Forbes","summary":"This Pharma Billionaire Is Developing A Cannabis Painkiller To Replace Dangerous Opioids - Forbes","headline":"This Pharma Billionaire Is Developing A Cannabis Painkiller To Replace Dangerous Opioids","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMijwFBVV95cUxQWGljaUlDTVZxSHM1Q1VsbVdyR1l6TjVha3p4VldZc25xemo1LXhXYWlKMWhaX3RxbkkyTGd4djlhSzhPTE5aOF9nQWVGamlUaV82ektBXzdnXzBuOFY0RUpSMHU5YlhTazlGSE5tMVpsZUFDYll1VE10dHdETVdzaEVxTlpaQXcwaWN4M1hTVQ?oc=5","date":"2025-03-18","type":"trial","source":"pharmaphorum","summary":"Vertanical's cannabis-based painkiller hits target in trials - pharmaphorum","headline":"Vertanical's cannabis-based painkiller hits target in trials","sentiment":"neutral"}],"patents":[],"drugCount":2,"phaseCounts":{"phase_3":2},"enrichmentLevel":0,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}